Tag Archives: Kenneth Allen Myszkowski

The CFO of Arrowhead Pharmaceuticals (NASDAQ: ARWR) is Selling Shares

Yesterday, the CFO of Arrowhead Pharmaceuticals (ARWR – Research Report), Kenneth Allen Myszkowski, sold shares of ARWR for $1.06M. Following Kenneth Allen Myszkowski’s last ARWR Sell transaction on February 27, 2020, the stock climbed by 44.1%. In addition to Kenneth

The CFO of Arrowhead Pharmaceuticals is Exercising Options

Yesterday it was reported that the CFO of Arrowhead Pharmaceuticals (ARWR – Research Report), Kenneth Allen Myszkowski, exercised options to buy 43,445 ARWR shares at $8.84 a share, for a total transaction value of $384.1K. This recent transaction increases Kenneth

The CFO of Arrowhead Research is Exercising Options

Yesterday it was reported that the CFO of Arrowhead Research (ARWR – Research Report), Kenneth Allen Myszkowski, exercised options to buy 12,649 ARWR shares at $5.19 a share, for a total transaction value of $65.65K. Following Kenneth Allen Myszkowski’s last